NCT02087540View on ClinicalTrials.gov

Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

PHASE3UnknownINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2014

Conditions
HypertensionHyperlipidemia
Interventions
DRUG

Telmisartan 80mg

DRUG

Rosuvastatin 20mg

DRUG

Rosuvastatin 10mg

DRUG

Placebo(for Telmisartan 80mg)

DRUG

Placebo(for Rosuvastatin 20mg)

DRUG

Placebo(for Rosuvastatin 10mg)

Trial Locations (1)

Unknown

RECRUITING

The Catholic University of Saint Mary's Hosiptal, Seoul

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02087540 - Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia | Biotech Hunter | Biotech Hunter